|
||
New findings reported in JAMA Oncology find that “current pricing models are not rational but simply reflect what the market will bear.” A new study published in JAMA Oncology investigated the pricing of new cancer drugs to determine what impacts the drug’s cost most: (1) a relative health benefit such as a very . . . → Read More: Five Years of Cancer Drug Approvals: Pricing Models Reflect What the Market Will Bear 
“Change the cancer conversation: The ‘war on cancer’ has run off course,” by Colin Macilwain, Nature. When Angelina Jolie had a double mastectomy in 2013 after genetic tests revealed her susceptibility to certain cancers, she urged others to consider their risk. Even more people will do so now that she has had her ovaries and . . . → Read More: The ‘war on cancer’ has run off course 
How one book shaped women’s health for forty years, and counting. Our Bodies, Ourselves — published by Boston Women’s Health Book Collective (1971) — has long been hailed as the “women’s health bible.” Envisioning women as informed and self-determined, capable of making empowered decisions, the book placed women’s health in a new socio-political context and . . . → Read More: Shaping Women’s Lives: Our Bodies, Ourselves
“Media Coverage of Angelina Jolie’s Choices for Cancer Prevention,” Health News Review. Health News Review evaluates health news using systematic criteria to assess the extent to which a news story uses independent sources, adequately addresses evidence, quantifies harms as well as benefits, identifies conflicts of interest, contributes to disease mongering, establishes the true novelty of . . . → Read More: Media Coverage of Angelina Jolie’s Choices for Cancer Prevention
On February 3, 2015, the U.S. Food and Drug Administration (FDA) approved a new drug for the treatment of ER+ (Estrogen-Receptor positive) and HER2- (Human Epidermal Growth Factor Receptor 2 –negative) breast cancers. The drug, called Ibrance (palbociclib) was granted FDA approval through the agency’s accelerated approval program, based on promising results from a Phase . . . → Read More: FDA Approves New Breast Cancer Drug
“Breast Biopsies Leave Room for Doubt, Study Finds,” Denise Grady, The New York Times. New findings reported in JAMA challenge the common belief that a biopsy is the gold standard and will resolve any questions that might arise from an unclear mammogram or ultrasound. In the United States, about 1.6 million women a year . . . → Read More: Breast Biopsies Leave Room for Doubt, Study Finds
“Lost in Transition After Cancer,” Suleika Jaouad, The New York Times Well Blog. Suleika Jaouad writes about the challenges faced by young adults, health, and her experiences with cancer. View the “Life, Interrupted” video series and read previous “Life, Interrupted” columns to learn more about Ms. Jaouad’s experiences. It is hard not to speak . . . → Read More: Lost in Transition After Cancer 
Opening Reception, Lown Institute 2015 The 2015 Lown Institute Conference was a wonderful opportunity to meet people I’ve been citing or communicating with about critical issues in health care and biomedicine for some time. It was also a chance to meet new friends and potential collaborators on this road to right care. At . . . → Read More: New Friends and Collaborators from the Lown Institute: Meet David Klemperer 
We are sad to share that our friend Lisa Bonchek Adams died of metastatic breast cancer on March 6th. Much love and strength to Lisa’s family, friends, and to all of us who listened to Lisa’s sound and pointed perspectives on breast cancer. From Lisa’s Blog, The thousands upon thousands who knew and . . . → Read More: Lisa Bonchek Adams, In Memoriam – March 6, 2015 
By Mariclare Barrett Mariclare Barrett is a friend of a friend. She is living with metastatic breast cancer and posted this status update on Facebook. Art by Kelly Rae Roberts I have good news today about my wrestle with late stage breast cancer: scans show my current chemotherapy regimen is working! The . . . → Read More: Facebook Status – Metastatic Breast Cancer |
||
| Copyright © 2025 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||